Skip to main content

Portfolio

HBM Healthcare Investments holds and manages a well-balanced portfolio with high value-creation potential.

Overview as at 31 December 2019

Currency allocation of assets

Emphasis on US dollar investments

56 340 US dollar (USD) 71 Renminbi (CNY) 11 Euro (EUR) 9 Indian rupee (INR) 4 Swiss franc (CHF) 3 Other currencies (CAD, DKK, GBP, HDK, SEK) 2 #AD2D3C #B7D4D8 #2E516C #6d7333 #CD8699 #53465e #f2a58f #94743a #cfa400 #3880C0
Allocation of assets

Mainly invested in private companies or in companies originating
from the private companies portfolio.

62 340 Public companies 46 Private companies 29 Cash and cash equivalents 15 Funds 9 Other assets 1 #AD2D3C #B7D4D8 #2E516C #6d7333 #CD8699 #53465e #f2a58f #94743a #cfa400 #3880C0
Development phase of portfolio companies

Mainly invested in revenue generating companies or in companies with products at an advanced stage of development.

69 90 Products on the market 22 Phase III 41 Phase II 16 Phase I 1 Preclinical 1 Profitable 19 #AD2D3C #B7D4D8 #2E516C #6d7333 #CD8699 #53465e #f2a58f #94743a #cfa400 #3880C0
Therapeutic area of the lead product of portfolio companies

Broadly diversified areas of activity.

79 350 Others 27 Oncology 20 Orphan diseases 13 Central nervous system 13 Immunology/Inflammation 13 Medical technology / diagnostics 4 Metabolic diseases 4 Digital Health 4 Infectious diseases 2 #AD2D3C #B7D4D8 #2E516C #6d7333 #CD8699 #53465e #f2a58f #94743a #cfa400 #3880C0